Bionova Scientific, a biologics CDMO with deep protein production, cell line development, process development and analytical expertise, has initiated construction of its new biologics manufacturing facility. Construction will be completed in approximately 10 months, with commissioning scheduled for Q3 2021.   The 36,000 sq. ft. facility will utilize single-use technologies for all core unit operations and is designed to accommodate two 2000L mammalian cell culture trains, capable of producing cl...